drugset

drugset / Trial / NCT00095069

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

NCT00095069 ↗

Phase 3 Completed 600 enrolled H. Lundbeck A/S

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.

Timeline

Start: 2004-10
Primary completion: 2007-02
Completion: 2007-02

Outcome

Missed primary endpoint

paper these differences were not significant. PMID 20191935 ↗

Publications

Roth T, Lines C, Vandormael K, Ceesay P, Anderson D, Snavely D. Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies. J Clin Sleep Med. 2010 Feb 15;6(1):30-9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gaboxadol	Unknown	15 mg	—

Indications